Literature DB >> 23465863

Chronic myopathy due to immunoglobulin light chain amyloidosis.

Irini Manoli1, Justin Y Kwan, Qian Wang, Elisabeth J Rushing, Maria Tsokos, Andrew E Arai, Warner M Burch, Angela Dispenzieri, Alexandra C McPherron, William A Gahl.   

Abstract

Amyloid myopathy associated with a plasma cell dyscrasia is a rare cause of muscle hypertrophy. It can be a challenging diagnosis, since pathological findings are often elusive. In addition, the mechanism by which immunoglobulin light-chain deposition stimulates muscle overgrowth remains poorly understood. We present a 53-year old female with a 10-year history of progressive generalized muscle overgrowth. Congo-red staining and immunohistochemistry revealed perivascular lambda light chain amyloid deposits, apparent only in a second muscle biopsy. The numbers of central nuclei and satellite cells were increased, suggesting enhanced muscle progenitor cell formation. Despite the chronicity of the light chain disease, the patient showed complete resolution of hematologic findings and significant improvement of her muscle symptoms following autologous bone marrow transplantation. This case highlights the importance of early diagnosis and therapy for this treatable cause of a chronic myopathy with muscle hypertrophy. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23465863      PMCID: PMC3608108          DOI: 10.1016/j.ymgme.2013.01.015

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  32 in total

Review 1.  A new look at the origin, function, and "stem-cell" status of muscle satellite cells.

Authors:  P Seale; M A Rudnicki
Journal:  Dev Biol       Date:  2000-02-15       Impact factor: 3.582

2.  Regenerative potential of human skeletal muscle during aging.

Authors:  Valérie Renault; Lars-Eric Thornell; Per-Olof Eriksson; Gillian Butler-Browne; Vincent Mouly; Lars-Eric Thorne
Journal:  Aging Cell       Date:  2002-12       Impact factor: 9.304

3.  The NIH Undiagnosed Diseases Program: lessons learned.

Authors:  William A Gahl; Cynthia J Tifft
Journal:  JAMA       Date:  2011-05-11       Impact factor: 56.272

Review 4.  Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.

Authors:  Morie A Gertz
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

Review 5.  The neuromuscular manifestations of amyloidosis.

Authors:  Zachary Simmons; Charles S Specht
Journal:  J Clin Neuromuscul Dis       Date:  2010-03

6.  Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival.

Authors:  A Dispenzieri; M Q Lacy; R A Kyle; T M Therneau; D R Larson; S V Rajkumar; R Fonseca; P R Greipp; T E Witzig; J A Lust; M A Gertz
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

7.  Cores in hypothyroid myopathy: a clinical, histological and immunofluorescence study.

Authors:  G Modi
Journal:  J Neurol Sci       Date:  2000-04-01       Impact factor: 3.181

8.  Amyloidotic muscle pseudohypertrophy: case report.

Authors:  R H Scola; L C Werneck; C S Ramos; R Pasquini; H Graf; W O Arruda
Journal:  Arq Neuropsiquiatr       Date:  2001-09       Impact factor: 1.420

9.  Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians.

Authors:  Nicolas Dupré; Nicolas Chrestian; Jean-Pierre Bouchard; Elsa Rossignol; Denis Brunet; Damien Sternberg; Bernard Brais; Jean Mathieu; Jack Puymirat
Journal:  Neuromuscul Disord       Date:  2008-03-11       Impact factor: 4.296

10.  The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases.

Authors:  William A Gahl; Thomas C Markello; Camilo Toro; Karin Fuentes Fajardo; Murat Sincan; Fred Gill; Hannah Carlson-Donohoe; Andrea Gropman; Tyler Mark Pierson; Gretchen Golas; Lynne Wolfe; Catherine Groden; Rena Godfrey; Michele Nehrebecky; Colleen Wahl; Dennis M D Landis; Sandra Yang; Anne Madeo; James C Mullikin; Cornelius F Boerkoel; Cynthia J Tifft; David Adams
Journal:  Genet Med       Date:  2011-09-26       Impact factor: 8.822

View more
  4 in total

1.  Muscle Hypertrophy in a Patient with Immunoglobulin D Multiple Myeloma.

Authors:  Shingo Suzuki; Yoshiyuki Ohira; Masatomi Ikusaka
Journal:  J Gen Intern Med       Date:  2016-05       Impact factor: 5.128

2.  The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine.

Authors:  William A Gahl; John J Mulvihill; Camilo Toro; Thomas C Markello; Anastasia L Wise; Rachel B Ramoni; David R Adams; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2016-01-22       Impact factor: 4.797

3.  The Need for a Consensus on the Locution "Central Nuclei" in Striated Muscle Myopathies.

Authors:  Anna L Mazzotti; Dario Coletti
Journal:  Front Physiol       Date:  2016-11-23       Impact factor: 4.566

Review 4.  Secondary myopathy due to systemic diseases.

Authors:  J Finsterer; W N Löscher; J Wanschitz; S Quasthoff; W Grisold
Journal:  Acta Neurol Scand       Date:  2016-02-25       Impact factor: 3.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.